Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany

被引：0
作者：
Tjalf Ziemssen
Michael Lang
Stephan Schmidt
Holger Albrecht
Luisa Klotz
Judith Haas
Christoph Lassek
Stefan Lang
Veronika E. Winkelmann
Benjamin Ettle
Ulf Schulze-Topphoff
机构：
[1] University of Technology,Center of Clinical Neuroscience, Neurological University Clinic Carl Gustav Carus
[2] NeuroPoint Patient Academy and Neurological Practice,Department of Neurology
[3] Health Center St. Johannes,Center for Multiple Sclerosis
[4] Neurological Practice,undefined
[5] University Hospital Münster,undefined
[6] Jewish Hospital Berlin,undefined
[7] Neurological Practice,undefined
[8] Kassel and Vellmar,undefined
[9] Scientific and Medical Writing,undefined
[10] Novartis Pharma GmbH,undefined
来源：
Journal of Neurology | 2022年 / 269卷
关键词：
Relapsing–remitting multiple sclerosis; Fingolimod; Real-world; Safety; Effectiveness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3276 / 3285
页数：9
相关论文
共 50 条
  • [31] Real-world persistence and benefit-risk profile of fingolimod over 36 months in Germany
    Ziemssen, Tjalf
    Lang, Michael
    Tackenberg, Bjoern
    Schmidt, Stephan
    Albrecht, Holger
    Klotz, Luisa
    Haas, Judith
    Lassek, Christoph
    Couto, C. Anne-Marie
    Findlay, John A.
    Cornelissen, Christian
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2019, 6 (03):
  • [32] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
    Batista, S.
    Nunes, C. C.
    Cerqueira, J. J.
    Martins Silva, Ana
    Correia de Sa, J.
    Ferreira, J.
    Mendonca, M. T.
    Pinheiro, J.
    Salgado, V.
    Correia, A. S.
    Sequeira, J.
    Costa, A.
    Sousa, L.
    NEUROLOGICAL SCIENCES, 2021, 42 (05) : 1995 - 2003
  • [33] Real-world evidence: Methods for assessing long-term health and effectiveness of allergy immunotherapy
    Fritzsching, Benedikt
    Contoli, Marco
    Porsbjerg, Celeste
    Buchs, Sarah
    Larsen, Julie Rask
    Freemantle, Nick
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 881 - 883
  • [34] Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
    Milanov, Ivan
    Ivanova, Sonya
    Tournev, Ivailo
    Chamova, Teodora
    Kaprelyan, Ara
    Slavov, Georgi
    Chervenkov, Vitan
    Kipriyanovska, Katerina
    REVISTA DE NEUROLOGIA, 2023, 77 : S1 - S7
  • [35] The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study
    Calvo-Garcia, Alberto
    Herraiz, Esther Ramirez
    Cubas, Irene Maria Llorente
    De Dios, Blanca Varas
    Gonzalez, Juana Benedi
    Baladron, Alberto Morell
    Garcia-Vicuna, Rosario
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [36] Long-term Efficacy and Safety of Pasireotide in Patients With Acromegaly: 14 Years of Single-Center Real-World Experience
    Gadelha, Monica
    Marques, Nelma Veronica
    Fialho, Christhiane
    Scaf, Cristiane
    Lamback, Elisa
    Antunes, Ximene
    Santos, Erica
    Magalhaes, Jaqueline
    Wildemberg, Luiz Eduardo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (12) : E1561 - E1569
  • [37] Nearly thirty years of experience of real-world long-term treatment with Agonists Opioid
    Lamanna, Francesco
    Maremmani, Angelo G. I.
    Maremmani, Icro
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2020, 22 (01) : 41 - 48
  • [38] Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn's disease - a real-world two-center cohort study
    Attauabi, Mohamed
    Vind, Ida
    Pedersen, Gitte
    Bendtsen, Flemming
    Seidelin, Jakob Benedict
    Burisch, Johan
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E709 - E718
  • [39] Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn's disease - a real-world two-center cohort study
    Attauabi, Mohamed
    Vind, Ida
    Pedersen, Gitte
    Bendtsen, Flemming
    Seidelin, Jakob Benedict
    Burisch, Johan
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E709 - E718
  • [40] Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
12345